Sleep · 2003
Report of a case of immunosuppression with prednisone in an 8-year-old boy with an acute onset of hypocretin-deficiency narcolepsy.
Клинический случайСтатьяПоддержка службы здравоохранения СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hecht Marketa, Lin Ling, Kushida Clete A, Umetsu Dale T, Taheri Shahrad, Einen Mali, Mignot Emmanuel
Аннотация
OBJECTIVE: To explore whether acute destruction of hypocretin cells in a patient with narcolepsy could be detected and if the course of the disease could be reversed or altered by the use of prednisone for immunosuppression.
DESIGN: Case report.
SETTING: A sleep-clinic population in a tertiary-care hospital.
PATIENT: An 8-year-old boy with a very acute recent (< 2 month) onset of sleepiness.
METHODS: Sleep studies; fluid-attenuated inversion recovery and gadolinium magnetic resonance imaging studies with a focus on the hypothalamus; examinations of cerebrospinal fluid for cytology, protein, and hypocretin-1 levels; and HLA typing were performed.
INTERVENTION: A 3-week regimen of 1 mg x kg(-1) x day(-1) of prednisone was administered in an attempt to modify the course of the disease.
RESULTS AND CONCLUSION: Sleep evaluations were consistent with a diagnosis of narcolepsy. Hypocretin-1 was absent in the cerebrospinal fluid, and HLA-DQB1*0602 was present. All other results were within normal limits, and prednisone did not have any noticeable effects. Clinical manifestation of narcolepsy might occur when the hypocretin cell damage is too advanced to be reversible.
DESIGN: Case report.
SETTING: A sleep-clinic population in a tertiary-care hospital.
PATIENT: An 8-year-old boy with a very acute recent (< 2 month) onset of sleepiness.
METHODS: Sleep studies; fluid-attenuated inversion recovery and gadolinium magnetic resonance imaging studies with a focus on the hypothalamus; examinations of cerebrospinal fluid for cytology, protein, and hypocretin-1 levels; and HLA typing were performed.
INTERVENTION: A 3-week regimen of 1 mg x kg(-1) x day(-1) of prednisone was administered in an attempt to modify the course of the disease.
RESULTS AND CONCLUSION: Sleep evaluations were consistent with a diagnosis of narcolepsy. Hypocretin-1 was absent in the cerebrospinal fluid, and HLA-DQB1*0602 was present. All other results were within normal limits, and prednisone did not have any noticeable effects. Clinical manifestation of narcolepsy might occur when the hypocretin cell damage is too advanced to be reversible.
Предметные рубрики MeSH
Acute DiseaseBenzhydryl CompoundsCarrier ProteinsCentral Nervous System StimulantsChildCyclohexanolsHLA AntigensHumansImmunosuppressive AgentsIntracellular Signaling Peptides and ProteinsMaleModafinilNarcolepsyNeuropeptidesOrexinsPolysomnographyPrednisoneSelective Serotonin Reuptake InhibitorsVenlafaxine Hydrochloride